Advertisement
Advertisement

AVBP

AVBP logo

ArriVent BioPharma, Inc. Common Stock

22.47
USD
Sponsored
-0.03
-0.15%
Jan 30, 16:00 UTC -5
Closed
exchange

After-Market

22.46

0.00
0.00%

AVBP Earnings Reports

Positive Surprise Ratio

AVBP beat 4 of 7 last estimates.

57%

Next Report

Date of Next Report
Mar 01, 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/
-$0.86
Implied change from Q3 25 (Revenue/ EPS)
--
/
+3.61%
Implied change from Q4 24 (Revenue/ EPS)
--
/
+40.98%

ArriVent BioPharma, Inc. Common Stock earnings per share and revenue

On Nov 10, 2025, AVBP reported earnings of -0.83 USD per share (EPS) for Q3 25, missing the estimate of -0.80 USD, resulting in a -3.09% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +3.08% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 15 analysts forecast an EPS of -0.86 USD, with revenue projected to reach -- USD, implying an increase of 3.61% EPS, and increase of 0.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Nurix Therapeutics, Inc. Common stock
Report Date
Jan 28, 2026 For Q4 25
Estimate
-$0.88
Actual
-$0.82
Surprise
+7.66%
logo
Regeneron Pharmaceuticals Inc
Report Date
Jan 30, 2026 For Q4 25
Estimate
$10.84
Actual
$11.44
Surprise
+5.52%
FAQ
For Q3 2025, ArriVent BioPharma, Inc. Common Stock reported EPS of -$0.83, missing estimates by -3.09%, and revenue of $0.00, 0% as expectations.
The stock price moved up 3.08%, changed from $18.05 before the earnings release to $18.60 the day after.
The next earning report is scheduled for Mar 01, 2026.
Based on 15 analysts, ArriVent BioPharma, Inc. Common Stock is expected to report EPS of -$0.86 and revenue of -- for Q4 2025.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement